• CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to Sell Rating

    Source: Buzz FX / 30 Dec 2024 23:52:13   America/New_York


    CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to Sell Rating Written by MarketBeat December 30, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) was upgraded by StockNews.com to a "sel
    Read more...
Share on,